Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_assertion type Assertion NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_head.
- NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_assertion description "[As estrogen receptor (ER) status is an important parameter in the development and progression of breast cancer, we analysed the effect of 17beta-estradiol (E2) treatment on the expression of A20.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_provenance.
- NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_assertion evidence source_evidence_literature NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_provenance.
- NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_assertion SIO_000772 17297453 NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_provenance.
- NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_assertion wasDerivedFrom befree-2016 NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_provenance.
- NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_assertion wasGeneratedBy ECO_0000203 NP593656.RACZT4a02nsj-R2zPhh5f2RLJRFasxH6NI4vJ_2GKl6m8130_provenance.